Clinical trial
Oct 2026
A multicenter, prospective, phase 2 trial on proton re‐irradiation for patients with previously treated head and neck cancer
Re‐irradiation (re‐RT) for recurrent head and neck cancer (HNC) can be potentially curative but is constrained by significant toxicity. Proton therapy may improve the therapeutic ratio. This multicenter phase 2 trial evaluated the safety and efficacy of proton re‐RT in patients with HNC.
E. Dee, C. A. Barker, N. Kalman et al.
· Cancer · 0 citations